Cresco Labs Inc. (CRLBF)
CRLBF Stock Price Chart
Explore Cresco Labs Inc. interactive price chart. Choose custom timeframes to analyze CRLBF price movements and trends.
CRLBF Company Profile
Discover essential business fundamentals and corporate details for Cresco Labs Inc. (CRLBF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
3 Dec 2018
Employees
2.90K
Website
https://www.crescolabs.comCEO
Charles Bachtell
Description
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of January 27, 2022, it owned and operated 48 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.
CRLBF Financial Timeline
Browse a chronological timeline of Cresco Labs Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 May 2026
Upcoming earnings on 10 Mar 2026
Upcoming earnings on 14 Nov 2025
EPS estimate is -$0.03.
Earnings released on 7 Aug 2025
EPS came in at -$0.05 falling short of the estimated -$0.04 by -25.00%, while revenue for the quarter reached $163.62M , missing expectations by -2.92%.
Earnings released on 30 May 2025
EPS came in at -$0.04 falling short of the estimated -$0.03 by -33.33%, while revenue for the quarter reached $165.76M , missing expectations by -2.85%.
Earnings released on 14 Mar 2025
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $175.91M , beating expectations by +4.99%.
Earnings released on 8 Nov 2024
EPS came in at -$0.02 falling short of the estimated -$0.00 by -474.71%, while revenue for the quarter reached $179.78M , beating expectations by +4.47%.
Earnings released on 8 Aug 2024
EPS came in at -$0.16 falling short of the estimated -$0.01 by -1.50K%, while revenue for the quarter reached $181.18M , missing expectations by -1.72%.
Earnings released on 15 May 2024
EPS came in at -$0.02 falling short of the estimated -$0.02 by -4.77%, while revenue for the quarter reached $183.47M , beating expectations by +0.15%.
Earnings released on 15 Mar 2024
EPS came in at $0.01 surpassing the estimated -$0.02 by +150.00%, while revenue for the quarter reached $193.44M , beating expectations by +6.39%.
Earnings released on 15 Nov 2023
EPS came in at -$0.04 matching the estimated -$0.04, while revenue for the quarter reached $190.56M , beating expectations by +4.81%.
Earnings released on 16 Aug 2023
EPS came in at -$0.05 falling short of the estimated -$0.04 by -25.00%, while revenue for the quarter reached $197.89M , beating expectations by +1.60%.
Earnings released on 24 May 2023
EPS came in at -$0.09 falling short of the estimated -$0.06 by -50.00%, while revenue for the quarter reached $194.20M , beating expectations by +1.18%.
Earnings released on 21 Mar 2023
EPS came in at -$0.03 falling short of the estimated -$0.01 by -118.82%, while revenue for the quarter reached $199.58M , missing expectations by -1.96%.
Earnings released on 15 Nov 2022
EPS came in at -$0.03 falling short of the estimated -$0.01 by -256.29%, while revenue for the quarter reached $210.48M , beating expectations by +0.03%.
Earnings released on 18 Aug 2022
EPS came in at -$0.05 falling short of the estimated -$0.01 by -558.76%, while revenue for the quarter reached $218.23M , missing expectations by -0.02%.
Earnings released on 18 May 2022
EPS came in at -$0.09 falling short of the estimated -$0.01 by -1.28K%, while revenue for the quarter reached $214.39M , beating expectations by +1.40%.
Earnings released on 25 Mar 2022
EPS came in at $0.01 falling short of the estimated $0.02 by -41.55%, while revenue for the quarter reached $217.79M , missing expectations by -7.11%.
Earnings released on 11 Nov 2021
EPS came in at $0.07 surpassing the estimated $0.01 by +975.27%, while revenue for the quarter reached $215.48M , missing expectations by -3.31%.
Earnings released on 13 Aug 2021
EPS came in at -$0.02 , while revenue for the quarter reached $209.98M .
Earnings released on 27 May 2021
EPS came in at -$0.12 , while revenue for the quarter reached $178.44M , beating expectations by +5.50%.
Earnings released on 25 Mar 2021
EPS came in at -$0.23 falling short of the estimated -$0.02 by -947.36%, while revenue for the quarter reached $170.84M .
Earnings released on 18 Nov 2020
EPS came in at -$0.03 surpassing the estimated -$0.08 by +62.50%, while revenue for the quarter reached $148.99M , missing expectations by -31.62%.
CRLBF Stock Performance
Access detailed CRLBF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.